Published in Dev Biol on January 15, 2001
GDF11 Increases with Age and Inhibits Skeletal Muscle Regeneration. Cell Metab (2015) 2.71
Redundancy of myostatin and growth/differentiation factor 11 function. BMC Dev Biol (2009) 1.56
Activation of the growth-differentiation factor 11 gene by the histone deacetylase (HDAC) inhibitor trichostatin A and repression by HDAC3. Mol Cell Biol (2004) 1.26
An antibody blocking activin type II receptors induces strong skeletal muscle hypertrophy and protects from atrophy. Mol Cell Biol (2013) 1.23
Foxg1 promotes olfactory neurogenesis by antagonizing Gdf11. Development (2009) 1.08
Both WFIKKN1 and WFIKKN2 have high affinity for growth and differentiation factors 8 and 11. J Biol Chem (2008) 1.03
Fras1, a basement membrane-associated protein mutated in Fraser syndrome, mediates both the initiation of the mammalian kidney and the integrity of renal glomeruli. Hum Mol Genet (2008) 0.99
Biochemistry and Biology of GDF11 and Myostatin: Similarities, Differences, and Questions for Future Investigation. Circ Res (2016) 0.98
Satellite cells in human skeletal muscle plasticity. Front Physiol (2015) 0.96
Transgenic over-expression of growth differentiation factor 11 propeptide in skeleton results in transformation of the seventh cervical vertebra into a thoracic vertebra. Mol Reprod Dev (2010) 0.94
Expression and function of BMP3 during chick limb development. Dev Dyn (2008) 0.93
Is Growth Differentiation Factor 11 a Realistic Therapeutic for Aging-Dependent Muscle Defects? Circ Res (2016) 0.85
GDF11 decreases bone mass by stimulating osteoclastogenesis and inhibiting osteoblast differentiation. Nat Commun (2016) 0.81
Through thick and thin: a circulating growth factor inhibits age-related cardiac hypertrophy. Circ Res (2013) 0.78
Transgenic overexpression of bone morphogenetic protein 11 propeptide in skeleton enhances bone formation. Biochem Biophys Res Commun (2011) 0.77
Growth/differentiation factor-11: an evolutionary conserved growth factor in vertebrates. Dev Genes Evol (2010) 0.76
Treatment with rGDF11 does not improve the dystrophic muscle pathology of mdx mice. Skelet Muscle (2016) 0.76
RNA Microarray Analysis of Macroscopically Normal Articular Cartilage from Knees Undergoing Partial Medial Meniscectomy: Potential Prediction of the Risk for Developing Osteoarthritis. PLoS One (2016) 0.76
Structural basis for potency differences between GDF8 and GDF11. BMC Biol (2017) 0.75
LncRNA-HIT Functions as an Epigenetic Regulator of Chondrogenesis through Its Recruitment of p100/CBP Complexes. PLoS Genet (2015) 0.75
Novel regulators of bone formation: molecular clones and activities. Science (1988) 10.74
Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol (1994) 5.93
Analysis of the tendon cell fate using Scleraxis, a specific marker for tendons and ligaments. Development (2001) 3.79
Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci U S A (1990) 3.52
Cathepsin S required for normal MHC class II peptide loading and germinal center development. Immunity (1999) 3.01
Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair. Clin Orthop Relat Res (1998) 2.73
Ectopic induction of tendon and ligament in rats by growth and differentiation factors 5, 6, and 7, members of the TGF-beta gene family. J Clin Invest (1997) 2.42
Bone morphogenetic protein-3 is a negative regulator of bone density. Nat Genet (2001) 2.34
The type I BMP receptor BMPRIB is required for chondrogenesis in the mouse limb. Development (2000) 2.30
Haemophilus influenzae type b bacteremia in adults with AIDS and at risk for AIDS. Am J Med (1992) 2.28
Identification of transforming growth factor beta family members present in bone-inductive protein purified from bovine bone. Proc Natl Acad Sci U S A (1990) 2.22
Differential roles for bone morphogenetic protein (BMP) receptor type IB and IA in differentiation and specification of mesenchymal precursor cells to osteoblast and adipocyte lineages. J Cell Biol (1998) 2.17
Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro. J Cell Biol (1991) 2.16
Purification and characterization of other distinct bone-inducing factors. Proc Natl Acad Sci U S A (1988) 2.13
Isolation of the human gene for bone gla protein utilizing mouse and rat cDNA clones. EMBO J (1986) 2.10
The non-osteogenic mouse pluripotent cell line, C3H10T1/2, is induced to differentiate into osteoblastic cells by recombinant human bone morphogenetic protein-2. Biochem Biophys Res Commun (1990) 1.88
The localized expression of extracellular matrix components in healing tendon insertion sites: an in situ hybridization study. J Orthop Res (2002) 1.85
Hypsographic demography: the distribution of human population by altitude. Proc Natl Acad Sci U S A (1998) 1.80
The healing of segmental bone defects, induced by recombinant human bone morphogenetic protein (rhBMP-2). A radiographic, histological, and biomechanical study in rats. J Bone Joint Surg Am (1992) 1.79
Recombinant human bone morphogenetic protein-2 induces osteoblastic differentiation in W-20-17 stromal cells. Endocrinology (1992) 1.75
A novel BMP expressed in developing mouse limb, spinal cord, and tail bud is a potent mesoderm inducer in Xenopus embryos. Dev Biol (1999) 1.64
Ghrelin increases food intake in obese as well as lean subjects. Int J Obes (Lond) (2005) 1.62
Transient upregulation of CBFA1 in response to bone morphogenetic protein-2 and transforming growth factor beta1 in C2C12 myogenic cells coincides with suppression of the myogenic phenotype but is not sufficient for osteoblast differentiation. J Cell Biochem (1999) 1.54
Bone morphogenetic proteins inhibit adipocyte differentiation by bone marrow stromal cells. J Cell Biochem (1995) 1.45
Pulmonary vasculitis--an uncommon complication of ulcerative colitis. Report of a case. N Engl J Med (1968) 1.44
Effect of apolipoprotein E genotype on hippocampal volume loss in aging healthy women. Neurology (2001) 1.43
Examination of reproductive aging milestones among women who carry the FMR1 premutation. Hum Reprod (2007) 1.42
Effects of BMP-2, BMP-4, and BMP-6 on osteoblastic differentiation of bone marrow-derived stromal cell lines, ST2 and MC3T3-G2/PA6. Biochem Biophys Res Commun (1996) 1.42
1,25-dihydroxycholecalciferol stimulates osteoclasts in rat bones in the absence of parathyroid hormone. Endocrinology (1981) 1.40
Bone morphogenetic protein-9 binds to liver cells and stimulates proliferation. Endocrinology (1995) 1.38
Heart specific expression of mouse BMP-10 a novel member of the TGF-beta superfamily. Mech Dev (1999) 1.35
Differential regulation of the two principal Runx2/Cbfa1 n-terminal isoforms in response to bone morphogenetic protein-2 during development of the osteoblast phenotype. Endocrinology (2001) 1.34
Unarmed, tumor-specific monoclonal antibody effectively treats brain tumors. Proc Natl Acad Sci U S A (2000) 1.32
Heterodimeric bone morphogenetic proteins show enhanced activity in vitro and in vivo. Growth Factors (1996) 1.32
Bone morphogenetic protein-2 inhibits terminal differentiation of myogenic cells by suppressing the transcriptional activity of MyoD and myogenin. Exp Cell Res (1997) 1.29
Consequences of reperfusion after coronary occlusion. Effects on hemodynamic and regional myocardial metabolic function. Am J Cardiol (1974) 1.28
Regulation of skeletal progenitor differentiation by the BMP and retinoid signaling pathways. J Cell Biol (2000) 1.18
Molecular heterogeneity in the Major Urinary Proteins of the house mouse Mus musculus. Biochem J (1996) 1.16
Cloning and expression of the Wnt antagonists Sfrp-2 and Frzb during chick development. Dev Biol (2000) 1.14
Leptin interacts with glucagon-like peptide-1 neurons to reduce food intake and body weight in rodents. FEBS Lett (1997) 1.13
Cassette-accelerated rapid rat screen: a systematic procedure for the dosing and liquid chromatography/atmospheric pressure ionization tandem mass spectrometric analysis of new chemical entities as part of new drug discovery. Rapid Commun Mass Spectrom (2001) 1.12
Overlapping roles for granulocyte-macrophage colony-stimulating factor and interleukin-3 in eosinophil homeostasis and contact hypersensitivity. Blood (2001) 1.10
Osteochondritis of the first metatarsal sesamoid: report of three cases. Clin Orthop Relat Res (1972) 1.07
A kinase domain-truncated type I receptor blocks bone morphogenetic protein-2-induced signal transduction in C2C12 myoblasts. J Biol Chem (1997) 1.06
Growth factors influencing bone development. J Cell Sci Suppl (1990) 1.03
A role for osteocalcin in osteoclast differentiation. J Cell Biochem (1991) 1.02
Changes in serum lipid concentrations during first 24 hours after myocardial infarction. Br Med J (Clin Res Ed) (1987) 1.00
Immunohistochemical detection of bone morphogenetic proteins in bone and soft-tissue sarcomas. Cancer (1994) 1.00
Cysticercus bovis in cattle in two beef feedlots in southern Ontario. Can Vet J (1994) 0.99
The pharmacology of RS-15385-197, a potent and selective alpha 2-adrenoceptor antagonist. Br J Pharmacol (1993) 0.98
Different effects of bone morphogenetic proteins 2, 4, 12, and 13 on the expression of cartilage and bone markers in the MC615 chondrocyte cell line. Exp Cell Res (1999) 0.97
Involvement of interleukin-3 in delayed-type hypersensitivity. Blood (1998) 0.95
Borderline papillary serous tumour of the fallopian tube. Am J Surg Pathol (1996) 0.95
Bone morphogenetic proteins-2 and -4 are involved in the retinoic acid-induced differentiation of embryonal carcinoma cells. Mol Biol Cell (1992) 0.94
Systematic LC/MS metabolite identification in drug discovery. Anal Chem (2001) 0.94
A mammalian serine/threonine kinase receptor specifically binds BMP-2 and BMP-4. Biochem Biophys Res Commun (1994) 0.94
The effects of aging on the bone inductive activity of recombinant human bone morphogenetic protein-2. Endocrinology (1996) 0.93
Independent changes in type I and type II receptors for transforming growth factor beta induced by bone morphogenetic protein 2 parallel expression of the osteoblast phenotype. Mol Cell Biol (1995) 0.93
The ultrastructure of osteoclasts in microphthalmic mice. Metab Bone Dis Relat Res (1981) 0.90
Orexin A immunoreactivity and preproorexin mRNA in the brain of Zucker and WKY rats. Neuroreport (2001) 0.86
Normal bone particles are preferentially resorbed in the presence of osteocalcin-deficient bone particles in vivo. Calcif Tissue Int (1991) 0.86
Time-related changes in the ultrastructure of osteoclasts after injection of parathyroid hormone in young rats. Calcif Tissue Int (1979) 0.86
Bone morphogenetic protein-12 and -13 inhibit terminal differentiation of myoblasts, but do not induce their differentiation into osteoblasts. Biochem Biophys Res Commun (1996) 0.84
Hysteretic behaviour of carnitine palmitoyltransferase. The effect of preincubation with malonyl-CoA. Biochem J (1986) 0.84
Application of machine learning methodology for PET-based definition of lung cancer. Curr Oncol (2010) 0.84
Expression of bone morphogenetic proteins in human osteosarcoma. Immunohistochemical detection with monoclonal antibody. Cancer (1994) 0.83
Androgen-binding proteins in human benign prostatic hypertrophy. J Clin Endocrinol Metab (1975) 0.82
Effects of GDF7/BMP12 on proliferation and alkaline phosphatase expression in rat osteoblastic osteosarcoma ROS 17/2.8 cells. J Cell Biochem (1999) 0.81
Characterization of bone morphogenetic protein 4 receptor in fibrodysplasia ossificans progressiva. Clin Orthop Relat Res (1998) 0.81
Recombinant human bone morphogenetic protein-2 induces a hematopoietic microenvironment in the rat that supports the growth of stem cells. Exp Hematol (1996) 0.81
Incompatibility of iron dextran and a total nutrient admixture. Am J Hosp Pharm (1990) 0.80
Nitrogen, phosphorus, and potassium uptake by wheat and their distribution in soil following successive, annual compost applications. J Environ Qual (2004) 0.80
Identification of ovarian granulosa cells as a novel site of expression for bone morphogenetic protein-3 (BMP-3/osteogenin) and regulation of BMP-3 messenger ribonucleic acids by chorionic gonadotropin in cultured human granulosa-luteal cells. J Clin Endocrinol Metab (1996) 0.80
Osteoclasts can be induced in fish having an acellular bony skeleton. Proc Natl Acad Sci U S A (1986) 0.80
Self-measurement of blood pressure: assessment of equipment. Canadian Coalition for High Blood Pressure Prevention and Control. Can J Cardiol (1995) 0.79
Inactivation of prostaglandins in human decidua vera (parietalis) tissue: substrate specificity of prostaglandin dehydrogenase. Am J Obstet Gynecol (1989) 0.79
A survey of post-amputation pains in serving military personnel. J R Army Med Corps (2013) 0.78
Neuroprotective properties of lifarizine compared with those of other agents in a mouse model of focal cerebral ischaemia. Br J Pharmacol (1995) 0.78
Changes in bone morphogenetic protein sensitivity relative to differentiation in fetal rat bone cell cultures. Ann N Y Acad Sci (1996) 0.78
Unilateral polycystic kidney disease. J Urol (1972) 0.78
Cellular characteristics of the rejection response to canine lung allotransplants. J Thorac Cardiovasc Surg (1973) 0.78
Cells of the mononuclear phagocytic system resorb implanted bone matrix: a histologic and ultrastructural study. Calcif Tissue Int (1982) 0.77
Opposing effects by glucocorticoid and bone morphogenetic protein-2 in fetal rat bone cell cultures. J Cell Biochem (1997) 0.77
Demonstration of the capabilities of a parallel high performance liquid chromatography tandem mass spectrometry system for use in the analysis of drug discovery plasma samples. Rapid Commun Mass Spectrom (1999) 0.77
Allele-specific RNA interference in FOP silencing the FOP gene. Gene Ther (2011) 0.76
Osteoclastic features of cells that resorb bone implants in rats. Calcif Tissue Int (1986) 0.75
Impaired osteoclast differentiation in subcutaneous implants of bone particles in osteopetrotic mutants. Bone Miner (1989) 0.75
Altered fetal pituitary-adrenal function in the ovine fetus treated with RU486 and meloxicam, an inhibitor of prostaglandin synthase-II. Biol Reprod (2000) 0.75
Direct current induced mosaic bone architecture. Clin Orthop Relat Res (1974) 0.75
Cadmium-induced experimental Fanconi syndrome. Curr Probl Clin Biochem (1975) 0.75
Effects of 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 on embryonic chick bone in organ culture. J Exp Zool (1982) 0.75
Intestinal disaccharidase deficiency in adults. N Z Med J (1968) 0.75
Trends in cardiovascular risk factors in Auckland, 1982 to 1987. N Z Med J (1990) 0.75
Electrical potentials in medullary bone. Clin Orthop Relat Res (1983) 0.75
Effects of parathyroid hormone and calcitonin on embryonic chick bone in organ culture. Gen Comp Endocrinol (1981) 0.75
Effects of serum calcium and phosphorus on skeletal mineralization in vitamin D-deficient rats. Am J Physiol (1986) 0.75
The influence of ridge migration on the magmatic segmentation of mid-ocean ridges. Nature (2004) 0.75
Effect of colored lenses on muscular performance. J Sports Med Phys Fitness (2014) 0.75
Stability of Revex, nalmefene hydrochloride injection. PDA J Pharm Sci Technol (1996) 0.75